Gibberellin A4A7 and Gibberellic acid: H113-12/2006-5E
Re-evaluation Decision Documents are used to announce the Agency's final decision concerning an active ingredient, which has been under re-evaluation in Canada. Re-evaluation Decision Documents may follow a Re-evaluation Note (REV) or a Proposed Acceptability for Continuing Registration (PACR). The document explains how the final decision was made.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.617721&sl=0
| Department/Agency |
|
|---|---|
| Title | Gibberellin A4A7 and Gibberellic acid |
| Series title |
|
| Publication type | Monograph - View Master Record |
| Language | [English] |
| Other language editions | [French] |
| Format | Physical text |
| Other formats | Digital text-[English] |
| Note(s) |
|
| Publishing information |
|
| Binding | Processed |
| Description | [2], 2p. ; 28 cm. |
| ISBN | 0-662-42734-3 |
| Catalogue number |
|
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: